FDA Inspection
GlaxoSmithKline Consumer Healthcare, LPGlaxoSmithKline Consumer Healthcare, LP – FDA Inspection, Jan 9, 2012
Record Details
This FDA Inspection record concerns GlaxoSmithKline Consumer Healthcare, LP, with an inspection on January 9, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 9, 2012
- Product Type
- Drugs
View Company Profile
ID · 683b974c-4381-4736-9dde-64c441a01a21
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 760651
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.